What does DENEUCARE do?

DENEUCARE is a specialist medical practice in Ottignies-Louvain-la-Neuve. Private Limited, started on 5 December 2002.

What is the address of DENEUCARE?

The registered office of DENEUCARE is located at Rue de Pallandt 7, 1341 Ottignies-Louvain-la-Neuve.

Is DENEUCARE still active?

Yes. According to the CBE (17 September 2026) DENEUCARE is active, legal situation “Normale toestand”, started on 5 December 2002.

Is DENEUCARE registered on Peppol?

Yes, DENEUCARE is registered on the Peppol network with ID 0208:0478940270.

What is the enterprise number of DENEUCARE?

The enterprise number of DENEUCARE is BE0478940270.

When was DENEUCARE founded?

DENEUCARE was founded on 5 December 2002.

Who are the directors of DENEUCARE?

According to the 2024 annual accounts, the directors of DENEUCARE are: Stéphane DENEU.

Is DENEUCARE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 December 2002; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did DENEUCARE make in 2024?

DENEUCARE posted a profit after taxes of € 98,460 in financial year 2024.

What is the revenue of DENEUCARE?

As a small company, DENEUCARE is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 186,593.

DENEUCARE (Private Limited) - Ottignies-Louvain-la-Neuve

Dossier DENEUCARE, printed on 17 September 2026 from databakkes.be/en/0478940270/deneucare. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

DENEUCARE from Ottignies-Louvain-la-Neuve, company number BE0478940270, closed financial year 2024 with a result of € 98,460 after tax. For that financial year DENEUCARE recorded a gross margin of € 186,593 and equity of € 1.3 million. Compared with financial year 2023, the result moved from € 86,692 to € 98,460. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2025.

What it is worth Growing

€ 1.3 million

▲ 8% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 98,460

▲ 14% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 528,980

▲ 9% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 1.2 million.

People and assets in 2024

Vehicles and equipment

€ 1,730

▲ 105% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 14 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 659,870

▼ 7% vs 2023

€ 45,619 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.

Owed to suppliers

€ 473

▼ 95% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 36,960

▲ 40% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 186,057 Gross margin 2021: € 186,057 First fiscal year in the series	€ 162,211 Gross margin 2022: € 162,211 ▼ 13% vs 2021 (€ 186,057) Unfavourable step	€ 162,534 Gross margin 2023: € 162,534 Unchanged (€ 162,211) Favourable step	€ 186,593 Gross margin 2024: € 186,593 ▲ 15% vs 2023 (€ 162,534) Favourable step	▲ 15%
Profit after taxes	€ 97,652 Profit after taxes 2021: € 97,652 First fiscal year in the series	€ 84,442 Profit after taxes 2022: € 84,442 ▼ 14% vs 2021 (€ 97,652) Unfavourable step	€ 86,692 Profit after taxes 2023: € 86,692 ▲ 3% vs 2022 (€ 84,442) Favourable step	€ 98,460 Profit after taxes 2024: € 98,460 ▲ 14% vs 2023 (€ 86,692) Favourable step	▲ 14%
Equity	€ 995,421 Equity 2021: € 995,421 First fiscal year in the series	€ 1,079,863 Equity 2022: € 1,079,863 ▲ 8% vs 2021 (€ 995,421) Favourable step	€ 1,166,555 Equity 2023: € 1,166,555 ▲ 8% vs 2022 (€ 1,079,863) Favourable step	€ 1,265,014 Equity 2024: € 1,265,014 ▲ 8% vs 2023 (€ 1,166,555) Favourable step	▲ 8%
Total debts	€ 934,146 Total debts 2021: € 934,146 First fiscal year in the series	€ 798,820 Total debts 2022: € 798,820 ▼ 14% vs 2021 (€ 934,146) Favourable step	€ 827,039 Total debts 2023: € 827,039 ▲ 4% vs 2022 (€ 798,820) Unfavourable step	€ 846,181 Total debts 2024: € 846,181 ▲ 2% vs 2023 (€ 827,039) Unfavourable step	▲ 2%
Cash	€ 504,959 Cash 2021: € 504,959 First fiscal year in the series	€ 492,748 Cash 2022: € 492,748 ▼ 2% vs 2021 (€ 504,959) Unfavourable step	€ 485,320 Cash 2023: € 485,320 ▼ 2% vs 2022 (€ 492,748) Unfavourable step	€ 528,980 Cash 2024: € 528,980 ▲ 9% vs 2023 (€ 485,320) Favourable step	▲ 9%
Land & buildings	€ 1,037,025 Land & buildings 2021: € 1,037,025 First fiscal year in the series	€ 1,013,515 Land & buildings 2022: € 1,013,515 ▼ 2% vs 2021 (€ 1,037,025) Unchanged	€ 990,004 Land & buildings 2023: € 990,004 ▼ 2% vs 2022 (€ 1,013,515) Unchanged	€ 966,494 Land & buildings 2024: € 966,494 ▼ 2% vs 2023 (€ 990,004) Unchanged	▼ 2%
Retained profit	€ 976,821 Retained profit 2021: € 976,821 First fiscal year in the series	€ 1,061,263 Retained profit 2022: € 1,061,263 ▲ 9% vs 2021 (€ 976,821) Favourable step	€ 1,147,955 Retained profit 2023: € 1,147,955 ▲ 8% vs 2022 (€ 1,061,263) Favourable step	€ 1,246,414 Retained profit 2024: € 1,246,414 ▲ 9% vs 2023 (€ 1,147,955) Favourable step	▲ 9%
Bank debt	€ 797,488 Bank debt 2021: € 797,488 First fiscal year in the series	€ 753,756 Bank debt 2022: € 753,756 ▼ 5% vs 2021 (€ 797,488) Favourable step	€ 709,403 Bank debt 2023: € 709,403 ▼ 6% vs 2022 (€ 753,756) Favourable step	€ 659,870 Bank debt 2024: € 659,870 ▼ 7% vs 2023 (€ 709,403) Favourable step	▼ 7%
Balance sheet total	€ 1,929,567 Balance sheet total 2021: € 1,929,567 First fiscal year in the series	€ 1,878,683 Balance sheet total 2022: € 1,878,683 ▼ 3% vs 2021 (€ 1,929,567) Unchanged	€ 1,993,594 Balance sheet total 2023: € 1,993,594 ▲ 6% vs 2022 (€ 1,878,683) Unchanged	€ 2,111,196 Balance sheet total 2024: € 2,111,196 ▲ 6% vs 2023 (€ 1,993,594) Unchanged	▲ 6%

Key figures of DENEUCARE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to DENEUCARE?

What happened at DENEUCARE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2025 New annual accounts for financial year 2024: profit of € 98,460 (▲ 14% vs 2023). filed late Source: NBB ↗
2023 Stéphane DENEU became a director. NBB
Dec 5, 2002 Start of the company according to the CBE. KBO

In short

From € 97,652 profit in 2021 to € 98,460 profit in 2024.

Paid € 156,336 in corporate taxes since 2021.

Best year ever: 2024, with € 98,460 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DENEUCARE? We notify you, reason included.

Follow DENEUCARE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Stéphane DENEU

DENEUCARE

Behind DENEUCARE is Stéphane DENEU.

See the full network in the app

Directors

According to the 2024 annual accounts

Stéphane DENEU

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Pallandt 7

1341 Ottignies-Louvain-la-Neuve

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

AVIATION TRADING BELGIUM

€ 51,318 gross margin · 2025

STREET ART RACING

€ 20,909 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0478.940.270
VAT number: BE 0478.940.270
Registered office: Rue de Pallandt 7, 1341 Ottignies-Louvain-la-Neuve
Names & denominations: DENEUCARE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 December 2002
Peppol: Active · Active since 8 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗